Site-selective radiolabeling using mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloaddition Journal Article


Authors: Rodriguez, C.; Delaney, S.; Sebastiano, J.; Sarrett, S. M.; Cornejo, M. A.; Thau, S.; Hosny, M. M.; Zeglis, B. M.
Article Title: Site-selective radiolabeling using mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloaddition
Abstract: We report the in vitro characterization and in vivo evaluation of a novel Zr-89-labeled radioimmunoconjugate synthesized using a site-selective bioconjugation strategy based on the oxidation of tyrosinase residues exposed by the deglycosylation of the IgG and the subsequent strain-promoted oxidation-controlled 1,2-quinone cycloaddition between these amino acids and trans-cyclooctene-bearing cargoes. More specifically, we site-selectively modified a variant of the A33 antigen-targeting antibody huA33 with the chelator desferrioxamine (DFO), thereby producing an immunoconjugate (DFO-(SPOCQ)huA33) with equivalent antigen binding affinity to its parent immunoglobulin but attenuated affinity for the Fc gamma RI receptor. This construct was subsequently radiolabeled with [Zr-89]Zr4+ to create a radioimmunoconjugate - [Zr-89]Zr-DFO-(SPOCQ)huA33 - in high yield and specific activity that exhibited excellent in vivo behavior in two murine models of human colorectal carcinoma.
Keywords: glycosylation; receptor; igg; binding
Journal Title: RSC Advances
Volume: 13
Issue: 26
ISSN: 2046-2069
Publisher: Royal Society of Chemistry  
Date Published: 2023-01-01
Start Page: 17705
End Page: 17709
Language: English
ACCESSION: WOS:001004470000001
DOI: 10.1039/d3ra03486k
PROVIDER: wos
PMCID: PMC10258682
PUBMED: 37313000
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brian Zeglis
    120 Zeglis
  2. Samantha Delaney
    12 Delaney
  3. Samantha Marga Sarrett
    11 Sarrett